Clinical Trials Browser

Completed × Carcinoma, Merkel Cell × avelumab × Clear all

NCT04393753 2024-05-08

MERKLIN2

Phase 2 Completed

Carcinoma, Merkel Cell

NCT02155647 2024-03-13

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Phase 2 Completed

204 enrolled 32 charts

Carcinoma, Merkel Cell